EULAV Asset Management Reduces Stake in Chemed Corporation $CHE

EULAV Asset Management lowered its holdings in Chemed Corporation (NYSE:CHE) by 61.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,605 shares of the company’s stock after selling 58,600 shares during the quarter. EULAV Asset Management’s holdings in Chemed were worth $15,662,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Parallel Advisors LLC increased its stake in shares of Chemed by 34.0% in the fourth quarter. Parallel Advisors LLC now owns 406 shares of the company’s stock worth $174,000 after acquiring an additional 103 shares during the period. Prudential PLC increased its stake in shares of Chemed by 56.7% in the fourth quarter. Prudential PLC now owns 2,232 shares of the company’s stock worth $955,000 after acquiring an additional 808 shares during the period. State of Wyoming increased its stake in shares of Chemed by 177.4% in the fourth quarter. State of Wyoming now owns 885 shares of the company’s stock worth $379,000 after acquiring an additional 566 shares during the period. TD Asset Management Inc increased its stake in shares of Chemed by 7.5% in the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after acquiring an additional 22,715 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in shares of Chemed by 37.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 158,093 shares of the company’s stock worth $67,642,000 after acquiring an additional 43,046 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of a number of research reports. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Sunday, May 31st. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada increased their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Oppenheimer cut their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $501.50.

Chemed Stock Up 1.9%

CHE stock opened at $440.67 on Friday. The firm has a market cap of $5.85 billion, a PE ratio of 24.01, a P/E/G ratio of 1.62 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The firm’s fifty day moving average is $409.41 and its 200 day moving average is $424.56. Chemed Corporation has a one year low of $365.20 and a one year high of $565.66.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the business earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is currently 13.08%.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 3.33% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.